Hiding under the skin: A welcome surprise in psoriasis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed.

1. In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17.The Journal of investigative dermatology · 2014
   Trial
2. Cutaneous Adverse Events Following Nemolizumab Administration: A Review.Journal of clinical medicine · 2025
   Review
3. Barium and psoriasis: a mini-review and hypothesis linking environmental exposures to ion channel modulation.Frontiers in medicine · 2025
   Review
4. Identification and validation of shared biomarkers and drug repurposing in psoriasis and Crohn's disease: integrating bioinformatics, machine learning, and experimental approaches.Frontiers in immunology · 2025
   Article
5. The Immunology of Psoriasis-Current Concepts in Pathogenesis.Clinical reviews in allergy & immunology · 2024
   Review
6. The association between psoriasis, psoriasis severity, and inflammatory bowel disease: a population-based analysis.Therapeutic advances in gastroenterology · 2024
   Article
7. γδ T cells: origin and fate, subsets, diseases and immunotherapy.Signal transduction and targeted therapy · 2023
   Review
8. Glutaminolysis and CD4Frontiers in immunology · 2022
   Review
9. Ozonated autohemotherapy elevates PPAR-γ expression in CD4American journal of translational research · 2021
   Article
10. Human CLAFrontiers in medicine · 2021
    Review
11. GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.The Journal of clinical investigation · 2020
    Article
12. Serum Adiponectin Levels and Their Association With Cardiometabolic Risk Factors in Patients With Psoriasis.Cureus · 2020
    Article
13. The influence of body weight of patients with chronic plaque psoriasis on biological treatment response.Postepy dermatologii i alergologii · 2020
    Review
14. Ozone Therapy Attenuates NF-κB-Mediated Local Inflammatory Response and Activation of Th17 Cells in Treatment for Psoriasis.International journal of biological sciences · 2020
    Article
15. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.The Journal of clinical investigation · 2018
    Article
16. miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis.The Journal of investigative dermatology · 2017
    Article
17. Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice.Experimental & molecular medicine · 2017
    Article
18. Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin.PloS one · 2016
    Article
19. IL-18 and Cutaneous Inflammatory Diseases.International journal of molecular sciences · 2015
    Review
20. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies.Nature medicine · 2015
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as